Physician profile
Roni Becker
NPI 1588437503
$572.26
in general payments reported to CMS, 2019-2025
12 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.22 · 2024: $92.24 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $169.07 | 2025 | Auvelity |
| Alkermes, INC. | $116.65 | 2025 | Lybalvi |
| Novo Nordisk INC | $58.97 | 2024 | Wegovy |
| Abbvie INC. | $40.50 | 2025 | |
| Vanda Pharmaceuticals INC. | $36.52 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.38 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $25.40 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $21.60 | 2025 | Austedo Xr |
| Tris Pharma INC | $18.68 | 2025 | Dyanavel Xr |
| Teleflex LLC | $18.22 | 2023 | Urolift |
| Mimedx Group, INC. | $17.91 | 2024 | |
| Braeburn INC. | $15.36 | 2024 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roni Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.